Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.35
- Piotroski Score 6.00
- Grade Outperform
- Symbol (DHR)
- Company Danaher Corporation
- Price $269.96
- Changes Percentage (-0.21%)
- Change -$0.56
- Day Low $268.65
- Day High $272.56
- Year High $281.70
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
- Last Earnings 09/10/2024
- Ex-Dividend for 5/16 Dividend 09/27/2024
- Dividend Payable 10/25/2024
- Today N/A
- Next Earnings (Estimated) 10/21/2024
- Fiscal Year End N/A
- Average Stock Price Target $312.50
- High Stock Price Target $365.00
- Low Stock Price Target $265.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $5.44
- Trailing P/E Ratio 48.36
- Forward P/E Ratio 48.36
- P/E Growth 48.36
- Net Income $4.76 B
Income Statement
Quarterly
Annual
Latest News of DHR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Cepheid Drives Danaher Corporation (DHR) Q2 2024 Success, Hedge Funds Rally Around the Stock
A recent article evaluates Danaher Corporation against other top healthcare stocks favored by hedge funds, highlighting the growth potential in the healthcare sector amidst economic challenges. Danahe...
By Yahoo! Finance | 5 days ago -
Danaher Corporation (DHR): Why Are Billionaires Bullish on This Stock Right Now?
Insider Monkey's article highlights Danaher Corporation (NYSE:DHR) as a top stock pick among billionaires due to its performance in the biotechnology and diagnostics sectors. The company's strategic i...
By Yahoo! Finance | 1 week ago -
Is Danaher Corporation (DHR) the Best Cancer Stock to Buy Now?
A list of the top 10 cancer stocks to invest in includes Danaher Corporation (NYSE:DHR), a global leader in healthcare technology. With a focus on improving human health through biotechnology and diag...
By Yahoo! Finance | 1 month ago
